Surgery Partners (NASDAQ:SGRY - Get Free Report) was downgraded by stock analysts at Mizuho from an "outperform" rating to a "neutral" rating in a research report issued to clients and investors on Wednesday, FinViz reports. They currently have a $25.00 target price on the stock, up from their prior target price of $19.00. Mizuho's price objective points to a potential downside of 6.47% from the stock's current price.
A number of other equities analysts also recently weighed in on SGRY. Zacks Research downgraded shares of Surgery Partners from a "strong-buy" rating to a "hold" rating in a report on Monday, August 10th. Cantor Fitzgerald cut shares of Surgery Partners from an "overweight" rating to a "hold" rating in a research note on Monday, October 26th. TD Cowen cut shares of Surgery Partners from a "strong-buy" rating to a "hold" rating in a research note on Saturday, October 31st. JPMorgan Chase & Co. lifted their price objective on shares of Surgery Partners from $14.00 to $15.00 and gave the company a "neutral" rating in a research report on Monday, September 14th. Finally, Weiss Ratings upgraded shares of Surgery Partners from a "sell (e+)" rating to a "sell (d-)" rating in a research note on Friday, October 16th. Two analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, Surgery Partners has an average rating of "Hold" and a consensus target price of $20.10.
Check Out Our Latest Report on SGRY
Surgery Partners Stock Up 1.1%
SGRY stock opened at $26.73 on Wednesday. The company has a market cap of $3.50 billion, a price-to-earnings ratio of -39.31 and a beta of 1.85. Surgery Partners has a twelve month low of $11.41 and a twelve month high of $27.23. The business has a 50 day moving average price of $16.55 and a two-hundred day moving average price of $14.94. The company has a quick ratio of 1.78, a current ratio of 1.95 and a debt-to-equity ratio of 1.18.
Surgery Partners (NASDAQ:SGRY - Get Free Report) last announced its quarterly earnings data on Monday, November 9th. The company reported $0.16 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.11 by $0.05. The company had revenue of $815.30 million for the quarter, compared to analysts' expectations of $820.96 million. Surgery Partners had a positive return on equity of 0.96% and a negative net margin of 2.59%. The business's revenue was down .8% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.13 EPS. Analysts anticipate that Surgery Partners will post 0.07 EPS for the current fiscal year.
Insider Buying and Selling
In other Surgery Partners news, Director Teresa DeLuca acquired 10,000 shares of the company's stock in a transaction on Tuesday, August 18th. The stock was acquired at an average price of $14.35 per share, for a total transaction of $143,500.00. Following the purchase, the director directly owned 66,843 shares of the company's stock, valued at $959,197.05. This trade represents a 17.59% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 2.00% of the company's stock.
Institutional Investors Weigh In On Surgery Partners
Several institutional investors and hedge funds have recently bought and sold shares of SGRY. Jefferies Financial Group Inc. acquired a new stake in Surgery Partners in the third quarter valued at approximately $560,000. Vise Technologies Inc. bought a new position in Surgery Partners in the 3rd quarter valued at approximately $191,000. State of Wyoming raised its holdings in Surgery Partners by 51.4% in the 3rd quarter. State of Wyoming now owns 23,568 shares of the company's stock valued at $327,000 after buying an additional 7,997 shares during the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new stake in Surgery Partners during the 3rd quarter worth approximately $426,000. Finally, Inspire Investing LLC boosted its position in Surgery Partners by 10.1% during the 3rd quarter. Inspire Investing LLC now owns 44,768 shares of the company's stock worth $621,000 after buying an additional 4,099 shares during the period.
Key Headlines Impacting Surgery Partners
Here are the key news stories impacting Surgery Partners this week:
- Positive Sentiment: The merger price was raised to $25 per share after a rival bid emerged. Reports say a Bon Secours affiliate’s offer could be worth up to $6 billion, and RBC suggested a revised competing offer is possible. The prospect of a higher bid has supported investor interest; however, the referenced $25 terms are below the $26.73 share price in the provided market data, leaving deal uncertainty. RBC on possible revised rival offer
- Positive Sentiment: Third-quarter adjusted EPS was $0.16, above estimates of $0.07–$0.11 and up from $0.13 a year earlier. Q3 earnings report
- Neutral Sentiment: RBC raised its price target from $23.50 to $25 but kept a “sector perform” rating. The higher target is still below the supplied share price, while RBC’s comments about a possible revised rival offer leave room for further deal developments.
- Negative Sentiment: Quarterly revenue of $815.3 million missed estimates and declined slightly year over year. The company also reported a $21.1 million net loss attributable to common shareholders, with weaker gross and operating profit—offset in part by improved operating cash flow.
- Negative Sentiment: Law firms announced investigations into the proposed transaction, raising questions about whether shareholders are receiving fair value. Such scrutiny could add uncertainty or delay; it does not establish wrongdoing. Shareholder buyout investigation notice
Surgery Partners Company Profile
(
Get Free Report)
Surgery Partners, Inc. is a U.S. healthcare services company that owns and operates ambulatory surgery centers and surgical hospitals. Its facilities provide outpatient and inpatient surgical care across a range of specialties. The company's services include surgical procedures and related care delivered in partnership with physicians and healthcare professionals. Its network serves patients in multiple states across the United States. Founded in 2004, Surgery Partners has expanded its network through acquisitions and partnerships with physicians and health systems.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Surgery Partners, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Surgery Partners wasn't on the list.
While Surgery Partners currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.